- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SPRC
Recent news which mentions SPRC
From Benzinga
Marijuana Stock Movers For August 8, 2023
August 08, 2023
From Benzinga
Cannabis Stock Movers For August 3, 2023
August 03, 2023
From Benzinga
Marijuana Stock Movers For August 2, 2023
August 02, 2023
From Benzinga
EXCLUSIVE: Clearmind Medicine Files US Patent Application For Dyskinesia Treatment, Strengthening Its IP Portfolio
August 01, 2023
From Benzinga
Marijuana Stock Movers For July 31, 2023
July 31, 2023
From Benzinga
Cannabis Stock Gainers And Losers From July 28, 2023
July 28, 2023
From Benzinga
Cannabis Stock Gainers And Losers From July 25, 2023
July 25, 2023
From Benzinga
SciSparc To Conduct Clinical Trial For Dronabinol-Based Drug To Treat Tourette Syndrome In Germany
July 03, 2023
Tickers
SPRC
From Benzinga
From InvestorPlace
EXCLUSIVE: SciSparc's Tourette Syndrome Candidate Receives IRB Approval To Start Phase 2b Study In US
June 21, 2023
Tickers
SPRC
From Benzinga
From Benzinga
The 7 Most Promising Penny Stocks to Buy in June
June 07, 2023
Tags
NASDAQ:REUN,NASDAQ:KXIN,NASDAQ:APLM,NASDAQ:MMV,NASDAQ:WLDS,NYSEAMERICAN:NNVC,NASDAQ:SPRC
Stocks to Buy
MMV
From InvestorPlace
SciSparc Nutraceuticals Granted An Exclusive License For The Sales Of CannAmide On The Amazon Marketplace In Canada
June 07, 2023
From Benzinga
Why A National Cannabis Organization Sacked Half Its Staff, CEO Turnovers And More Exec Changes
June 05, 2023
From Benzinga
Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 02, 2023
From Benzinga
New Drug Based On FDA-Approved Synthetic THC And CannAmide Shows Promise In Treating Agitation In Alzhemier's
June 02, 2023
Tickers
SPRC
From Benzinga
From InvestorPlace
Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More
April 24, 2023
From Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 21, 2023
From Benzinga
SciSparc And Clearmind Collaboration Strengthens IP Portfolio With Patent Application For Treatment Of Depression
April 21, 2023
From Benzinga
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 11, 2023
From Benzinga
From InvestorPlace
Stocks That Hit 52-Week Lows On Friday
March 31, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 28, 2023
From Benzinga
From InvestorPlace
SciSparc Completes Production Of Its Dronabinol-Based Drug Candidate For Its Clinical Trial On Tourette Syndrome
March 06, 2023
Tickers
SPRC
From Benzinga
Psyched: Hawaii And Minnesota's Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry's Future And More
February 27, 2023
From Benzinga
SciSparc's CBD-Based Drug One Step Closer To Clinical Trial On Children With Autism Spectrum Disorder
February 27, 2023
Tickers
SPRC
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.